Pilnik Richard D. 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Pilnik Richard D.
Director
Transactions
- Award
Voting Common Shares, no par value per share
2025-01-02$5.34/sh+10,393$55,499→ 288,995 total
Footnotes (2)
- [F1]These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $55,500. The deferred stock units will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.
- [F2]Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time.